INCY vs NDAQ · P/E 14, rev $5.14B vs P/E 41, rev $2.53B
Incyte Corporation (INCY) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the INCY and NDAQ stock pages for the full models.
Not investment advice.